Sansure Biotech Inc.’s Net Profit Dropped 90.8% in First Quarter of 2023

Sansure Biotech Inc. (圣湘生物科技股份有限公司) (688289.SH) reported a net profit of 60 million yuan in the first quarter of 2023, down 90.8% year-on-year.

Meanwhile, the company posted 195.2 million yuan in revenue, down 86.4% year-on-year.

At the end of the reporting period, it had 8.7 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 13.2%.